Based on our results, this example of p52-mediated reprogramming is sufficient to disrupt the phosphorylation of p38, ultimately boosting JNK activity and impacting myeloma proliferation (Fig. 6h). The gene discussed is GRAP2; the disease is plasma cell myeloma.